The Venari Growth Podcast

Venari Partners
  • 0.0 (0)
  • CAREERS

In this series our consultants speak to business leaders on how they are uncovering the pathways to profitable and strategic growth.

  1. 07/17/2024

    ‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’ | Manfred Ruediger

    ‘I’ve been doing this for a long, long time. I think it’s a very rewarding thing to do.’ This episode of the Venari Podcast’s Talking Radiopharma series saw Matthew Palmer speak to Ariceum Therapeutics CEO Manfred Ruediger. A serial biotech entrepreneur, Manfred has worked in executive functions in biotech for almost 25 years. Ariceum’s development of novel targeted radiopharmaceuticals for cancer treatment – as well as Manfred’s considerable experience building out companies – certainly offered plenty of scope for discussion. Tune in to hear more about what Ariceum do differently, plus Manfred’s thoughts on team building and his advice for the radiopharmaceutical innovators of tomorrow! Our thanks to the Ariceum CEO and his team for this fascinating podcast.

    15 min

  2. 06/04/2024

    "You learn so much when you take a role outside of your home market” | Eric Luthi

    “I can say definitively that the years working abroad were the most formative from a career and personal perspective – you learn so much when you take a role outside of your home market”. Fabulous to welcome Eric Luthi, Evergreen Theragnostics’s (relatively) recently appointed Chief Commercial Officer, to the Venari Podcast. We discuss building commercial infrastructure from scratch, how international experience has shaped his career and getting into the exciting world of radiopharmaceuticals.  Radiopharma is a space that my colleague Matthew Palmer and I are doing a lot of work in currently, both on the R&D and commercial side. Get in touch if you’d like to learn more!

    16 min

  3. 06/04/2024

    ‘Understand the role. Know what a Chief Commercial Officer does’ | Kerry Clem

    ‘I’ve always had the attitude that whatever is needed, wherever you need me to fill in, just let me know and we’ll take it on,’ says Acorda Therapeutics CCO, Kerry Clem. ‘I think that was one of the main things that helped me to elevate and grow.’ He’s amassed a wealth of commercial life sciences experience over her 25 years in the industry, joking that 13 years at Acorda alone make him ‘a relic in this industry’ – and so he was a natural candidate for inclusion on the BioPharma Chief Commercial Officer series for the Venari Podcast, run by our Life Sciences Commercial Lead, Joe Knight.

    15 min

  4. 01/03/2024

    Packaging entrepreneurship within a wider organisation | Fabrice Clerc-Renaud

    Fabrice Clerc-Renaud has had a varied career in the packaging space – and developed a product, ePack, almost as a startup within the organisation he was working for (DS Smith). Tim Hartnell, our Senior Sustainable Packaging Consultant, caught up with Fabrice on the Venari Podcast; you can find the full transcript of their interview here.

    10 min

  5. 08/31/2023

    BioTech Commercialisation & Working Within Pharma Partnerships | Eric Matthews

    For the final episode of the Venari Podcast’s first Chief Commercial Officer series, Joe Knight, Commercial Consultant for our Life Sciences practice, spoke to Arcus Biosciences’ CCO Eric Matthews. His career has taken in some of the biggest names in the industry, tallying with a recurring theme of the series: the journey from roles in Big Pharma to a CCO position in a smaller biotech.

    16 min

  6. 08/21/2023

    Executing Effective Commercialisation Strategies: E.U. Vs U.S. | Kirsten Detrick

    With over 30 years’ experience in launching and leading multi-billion-dollar blockbuster drug launches, Kirsten Detrick is more than qualified to discuss what is needed for successful commercial strategies in biopharma. She was most recently CCO at Endpoint Health, and remains sought-after by biotechs preparing for commercialisation. Kirsten spoke to our Life Sciences Commercial Consultant, Joe Knight, for the Venari Podcast Chief Commercial Officer series. Listen to their conversation which touched on Kirsten’s journey towards becoming a CCO, commercialisation and talent strategies!

    14 min

  7. 08/11/2023

    Launching in Rare Disease & Using Big Pharma Experience in a Biotech Setting | Johanna Rossell

    ‘You can’t afford to drag with suboptimal performance.’ Johanna Rossell, SVP General Manager Rare Diseases at Sumitomo Pharma America, has a wide range of professional experience to draw on when it comes to commercial biopharma. Her career has taken in stints in marketing and commercial across South America, Switzerland, and the US for a number of large companies prior to her recent experience as CCO of Enzyvant. Joe Knight, our Life Sciences Commercial Consultant, welcomed Johanna to the Venari Podcast for another episode of the Chief Commercial Officer series, where she opened up on what she’s learned from launches, when to bring in commercial teams, and her leadership philosophy of the ‘coach manager: the coach that can lead the multi-functional team’ while thinking long-term.

    9 min

  8. 07/14/2023

    Mobilising A Team To Succeed & Long-term Commercial Strategies | Greg Gangemi

    ‘Launching a product is one of the most exciting things you can do.’ Life sciences product launches can be thrilling – if challenging. They require meticulous planning, a strong value proposition, and effective market access strategies – and Greg Gangemi knows all about this. Joe Knight, our Life Sciences Commercial Consultant, was delighted to host Greg on an episode of the Venari Podcast’s Chief Commercial Officer series.

    10 min
See All (18)

About

In this series our consultants speak to business leaders on how they are uncovering the pathways to profitable and strategic growth.

Information